Perrigo Co PLC (PRGO)
25.44
-0.75
(-2.86%)
USD |
NYSE |
Jul 05, 16:00
25.46
+0.02
(+0.08%)
After-Hours: 20:00
Perrigo Research and Development Expense (Annual): 122.50M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 122.50M |
| December 31, 2022 | 123.10M |
| December 31, 2021 | 122.00M |
| December 31, 2020 | 121.70M |
| December 31, 2019 | 119.20M |
| December 31, 2018 | 218.60M |
| December 31, 2017 | 167.70M |
| December 31, 2016 | 184.00M |
| December 31, 2015 | 88.20M |
| June 30, 2015 | 187.80M |
| June 30, 2014 | 152.50M |
| June 30, 2013 | 115.20M |
| June 30, 2012 | 105.80M |
| June 30, 2011 | 89.30M |
| June 30, 2010 | 83.52M |
| June 30, 2009 | 77.92M |
| Date | Value |
|---|---|
| June 30, 2008 | 72.19M |
| June 30, 2007 | 66.48M |
| June 30, 2006 | 52.29M |
| June 30, 2005 | 38.42M |
| June 30, 2004 | 27.72M |
| June 30, 2003 | 23.32M |
| June 30, 2002 | 25.69M |
| June 30, 2001 | 17.63M |
| June 30, 2000 | 16.31M |
| June 30, 1999 | 14.87M |
| June 30, 1998 | 15.90M |
| June 30, 1997 | 13.70M |
| June 30, 1996 | |
| June 30, 1995 | |
| June 30, 1994 | 6.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
119.20M
Minimum
2019
123.10M
Maximum
2022
121.70M
Average
122.00M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Alkermes PLC | 270.81M |
| Jazz Pharmaceuticals PLC | 849.66M |
| Medtronic PLC | 2.735B |
| Trinity Biotech PLC | 4.379M |
| Iterum Therapeutics PLC | 39.99M |